CA2438330A1 - Methode pour le depistage precoce du cancer - Google Patents

Methode pour le depistage precoce du cancer Download PDF

Info

Publication number
CA2438330A1
CA2438330A1 CA002438330A CA2438330A CA2438330A1 CA 2438330 A1 CA2438330 A1 CA 2438330A1 CA 002438330 A CA002438330 A CA 002438330A CA 2438330 A CA2438330 A CA 2438330A CA 2438330 A1 CA2438330 A1 CA 2438330A1
Authority
CA
Canada
Prior art keywords
cells
dutt1
cancer
population
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002438330A
Other languages
English (en)
Inventor
Pamela Rabbitts
Terence Howard Rabbitts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0123630A external-priority patent/GB0123630D0/en
Priority claimed from GB0127668A external-priority patent/GB0127668D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of CA2438330A1 publication Critical patent/CA2438330A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des procédés destinés au diagnostic, à l'imagerie et au traitement de cellules cancéreuses. L'invention concerne plus particulièrement l'utilisation d'une molécule suppresseur de tumeur qui est apparente à des densités supérieures sur des cellules cancéreuses que sur des cellules se divisant normalement pour le diagnostic, l'imagerie, la prophylaxie et le traitement du cancer.
CA002438330A 2001-10-02 2002-10-02 Methode pour le depistage precoce du cancer Abandoned CA2438330A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0123630.6 2001-10-02
GB0123630A GB0123630D0 (en) 2001-10-02 2001-10-02 cancer
GB0127668.2 2001-11-19
GB0127668A GB0127668D0 (en) 2001-11-19 2001-11-19 Cancer
PCT/GB2002/004445 WO2003029488A2 (fr) 2001-10-02 2002-10-02 Cancer

Publications (1)

Publication Number Publication Date
CA2438330A1 true CA2438330A1 (fr) 2003-04-10

Family

ID=26246602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002438330A Abandoned CA2438330A1 (fr) 2001-10-02 2002-10-02 Methode pour le depistage precoce du cancer

Country Status (4)

Country Link
EP (1) EP1432821A2 (fr)
JP (1) JP2005504307A (fr)
CA (1) CA2438330A1 (fr)
WO (1) WO2003029488A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101014860B (zh) * 2004-03-31 2012-01-25 中外制药株式会社 抗-robo1抗体用于制备癌症治疗药物及相关诊断试剂盒
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗robo1抗体を含むpet用腫瘍診断剤
WO2010131590A1 (fr) * 2009-05-14 2010-11-18 国立大学法人 東京大学 Agent diagnostique et agent thérapeutique pour des tumeurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020764A1 (fr) * 1997-10-20 1999-04-29 The Regents Of The University Of California Robo : une famille de polypeptides et d'acides nucleiques impliques dans le guidage des nerfs
JP2001523458A (ja) * 1997-11-14 2001-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 神経細胞機能の調節方法

Also Published As

Publication number Publication date
JP2005504307A (ja) 2005-02-10
EP1432821A2 (fr) 2004-06-30
WO2003029488A3 (fr) 2003-07-03
WO2003029488A2 (fr) 2003-04-10

Similar Documents

Publication Publication Date Title
KR102618312B1 (ko) 항muc16 항체 및 그의 용도
CA2598510C (fr) Sparc mutant a deletion q3 et utilisations dudit polypeptide mutant
ES2308787T3 (es) Antigenos de superficie de celular de mamiferos; reactivos relacionados.
JP3682926B2 (ja) 多薬物耐性遺伝子
EP2261242A1 (fr) Enzyme aspartate-N-acétyltransférase, procédé de diagnostic et procédé thérapeutique
JPH09509570A (ja) Mts−1遺伝子により転移性癌の診断
JP2004113151A (ja) 癌遺伝子及びその用途
JP2007197439A (ja) 中皮抗原及びそれを標的化するための方法及びキット
US20030086929A1 (en) Treatment of prostate cancer by inhibitors of ATP synthase
KR20020073181A (ko) Liv-1 관련 단백질, 이를 코딩하는 폴리뉴클레오티드및 암의 치료를 위한 그의 용도
EP1351968B1 (fr) Mutations dans la sous-unite alpha1 du canal sodique du gene neuronal, polypeptides associes, et traitement du syndrome gefs+ (epilepsie generalisee avec crises febriles +)
JP3779989B2 (ja) リンパ抗原cd30
WO2001096359A1 (fr) Compositions, procedes et kits relatifs a des molecules du type resistine
CA2150789A1 (fr) Serine/threonine kinase
JP4365583B2 (ja) ノッチレセプターアゴニスト及び用途
CA2438330A1 (fr) Methode pour le depistage precoce du cancer
WO2007037245A1 (fr) Polypeptide présentant une activité anti-angiogénique
AU2002329437A1 (en) A method for the early detection of cancer
JP3911017B2 (ja) 腫瘍遺伝子Int6のヌクレオチド配列及び推定アミノ酸配列
JP2004534525A (ja) uPAR変異体del4、del5およびdel4+5に対する単特異性のポリクローナル抗体の製法並びに診断および治療目的のためのその使用
US20040191791A1 (en) Novel mutation
JP2003116560A (ja) 新規なポリペプチド及びそれをコードするポリヌクレオチド
CA2447958A1 (fr) Facteurs activant l'hypoxie et utilisation de ces facteurs pour activer l'angiogenese et ameliorer les fonctions musculaires
US7087715B2 (en) Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
JP2004511758A (ja) 大腸癌の診断、モニタリング、ステージング、イメージングおよび処置の方法

Legal Events

Date Code Title Description
FZDE Dead